Richard Jackson1,2, Elizabeth Ross3, Jemy Jose3. 1. Department of ENT, Hull Teaching Hospitals, Hull, HU16 5JQ, UK. Richard.jackson12@nhs.net. 2. Department of ENT, Castlehill Hospital, Cottingham, HU16 5JQ, UK. Richard.jackson12@nhs.net. 3. Department of ENT, Hull Teaching Hospitals, Hull, HU16 5JQ, UK.
Abstract
PURPOSE: Transoral surgery for suspected or proven oropharyngeal malignancies has increased significantly with the practice of transoral laser microsurgery (TLM) and transoral robotic surgery (TORS). An accepted alternative technique is endoscopic video-assisted transoral (EVAT) surgery. Our aim is to review the clinical, oncological and functional outcomes of this technique at our institution. METHODS: 56 consecutive patients undergoing EVAT surgery as part of their cancer work up or treatment were reviewed, focusing on clinical, oncological, and functional outcomes. RESULTS: Patients had primary oropharyngeal cancer or carcinoma of unknown primary (CUP) staged between T0-T3 and N0-N3. EVAT surgery identified a primary in 47.1% of CUP with p16 positive disease. Major haemorrhage occurred in 1.8%, with eight post-operative complications. 8.9% of patients developed locoregional recurrence. Mean MD Anderson Dysphagia Inventory score was 76.4 following EVAT surgery, 68.8 after EVAT surgery + radiotherapy and 67.1 after EVAT surgery + chemoradiotherapy CONCLUSION: Early clinical, oncological and functional outcomes following EVAT surgery are comparable to TLM and TORS. LEVEL OF EVIDENCE: 4 (case series).
PURPOSE: Transoral surgery for suspected or proven oropharyngeal malignancies has increased significantly with the practice of transoral laser microsurgery (TLM) and transoral robotic surgery (TORS). An accepted alternative technique is endoscopic video-assisted transoral (EVAT) surgery. Our aim is to review the clinical, oncological and functional outcomes of this technique at our institution. METHODS: 56 consecutive patients undergoing EVAT surgery as part of their cancer work up or treatment were reviewed, focusing on clinical, oncological, and functional outcomes. RESULTS:Patients had primary oropharyngeal cancer or carcinoma of unknown primary (CUP) staged between T0-T3 and N0-N3. EVAT surgery identified a primary in 47.1% of CUP with p16 positive disease. Major haemorrhage occurred in 1.8%, with eight post-operative complications. 8.9% of patients developed locoregional recurrence. Mean MD Anderson Dysphagia Inventory score was 76.4 following EVAT surgery, 68.8 after EVAT surgery + radiotherapy and 67.1 after EVAT surgery + chemoradiotherapy CONCLUSION: Early clinical, oncological and functional outcomes following EVAT surgery are comparable to TLM and TORS. LEVEL OF EVIDENCE: 4 (case series).
Authors: K Kian Ang; Jonathan Harris; Richard Wheeler; Randal Weber; David I Rosenthal; Phuc Felix Nguyen-Tân; William H Westra; Christine H Chung; Richard C Jordan; Charles Lu; Harold Kim; Rita Axelrod; C Craig Silverman; Kevin P Redmond; Maura L Gillison Journal: N Engl J Med Date: 2010-06-07 Impact factor: 91.245
Authors: Timo Carpén; Anni Sjöblom; Marie Lundberg; Caj Haglund; Antti Markkola; Stina Syrjänen; Jussi Tarkkanen; Antti Mäkitie; Jaana Hagström; Petri Mattila Journal: Acta Otolaryngol Date: 2017-11-21 Impact factor: 1.494
Authors: Ahmed S Ibrahim; Francisco J Civantos; Jason M Leibowitz; Giovana R Thomas; David J Arnold; Elizabeth J Franzmann; Elizabeth A Nicolli; Kaming Lo; Zsuzsanna Nemeth; Zoukaa B Sargi; Donald T Weed Journal: Head Neck Date: 2019-01-28 Impact factor: 3.147
Authors: Peter T Dziegielewski; Theodoros N Teknos; Kasim Durmus; Matthew Old; Amit Agrawal; Kiran Kakarala; Anna Marcinow; Enver Ozer Journal: JAMA Otolaryngol Head Neck Surg Date: 2013-11 Impact factor: 6.223
Authors: Mark D Wilkie; Navdeep S Upile; Andrew S Lau; Stephen P Williams; Jon Sheard; Tim R Helliwell; Max Robinson; Jennifer Rodrigues; Krishna Beemireddy; Huw Lewis-Jones; Rebecca Hanlon; David Husband; Aditya Shenoy; Nicholas J Roland; Shaun R Jackson; Fazilet Bekiroglu; Sankalap Tandon; Jeffrey Lancaster; Terence M Jones Journal: Head Neck Date: 2016-04-04 Impact factor: 3.147